AIM ImmunoTech Inc.

AIM NYSE SEC CIK 946644
Follow AIM ImmunoTech Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $22K −15.4% vs same quarter last year
Net income −$3.1M +4.3% vs same quarter last year
EPS, diluted −$0.21 +86.6% vs same quarter last year
Operating cash flow −$2.9M +42.3% vs same quarter last year
Revenue by quarter
$45K
$16K
$25K
$26K
$21K
$22K
$26K
$22K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$88K−$14M
FY24$170K−$17.3M
FY23$202K−$29M
FY22$141K−$19.4M
FY21$135K−$19.1M
FY20$163K−$14.4M
FY19$140K−$9.4M
FY18$367K−$9.8M
FY17$437K−$8.3M
FY16$92K−$7.5M
FY15$133K−$15.2M
FY14$197K−$17.5M
FY13$150K−$16.2M
FY12$213K−$17.4M
FY11$161K−$9M
MarginsShare of revenue
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−13254.5%−15861.4%
FY24−11630.6%−10188.2%
FY23−15800%−14337.6%
FY22−14129.8%−13790.8%
FY21−13954.1%−14168.1%
FY20−9295.7%−8834.4%
FY19−8887.9%−6717.1%
FY18−3132.4%−2677.7%
FY17−2612.4%−1889.9%
FY16−15004.3%−8154.3%
FY15−12518.8%−11451.1%
FY14−9694.9%−8857.9%
FY13−11444.7%−10816.7%
FY12−9549.3%−8147.4%
FY11−8878.9%−5599.4%
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$14.9M
FY23-
FY22−$16.2M
FY21−$14M
FY20−$10.4M
FY19−$9.1M
FY18−$10.7M
FY17−$8M
FY16−$7.5M
FY15−$16.3M
FY14−$14.5M
FY13−$17.7M
FY12−$18.9M
FY11−$11.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • AIM ImmunoTech
  • Healthcare median
−20000%−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAIM ImmunoTechHealthcare median
FY25−15861.4%−30.6%
FY24−10188.2%−47%
FY23−14337.6%−58%
FY22−13790.8%−80.4%
FY21−14168.1%−71.9%
FY20−8834.4%−62.2%
FY19−6717.1%−46.3%
FY18−2677.7%−49.6%
FY17−1889.9%−45.9%
FY16−8154.3%−36%
FY15−11451.1%−38.4%
FY14−8857.9%−35.5%
FY13−10816.7%−37.1%
FY12−8147.4%−29.1%
FY11−5599.4%−27.9%